Skip to main content
SpringerLink
Log in

T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Multidrug-resistant uropathogenic Escherichia coli (UPEC) is increasing gradually on a worldwide scale. We therefore examined the possibility of bacteriophage (phage) therapy for urinary tract infections (UTIs) caused by the UPEC strains as an alternative to chemotherapy. In addition to the well-known T4 phage, KEP10, which was newly isolated, was used as a therapeutic phage candidate. KEP10 showed a broader bacteriolytic spectrum (67%) for UPEC strains than T4 (14%). Morphological and genetic analyses showed that KEP10 resembles phage T4. Phages T4 and KEP10 injected into the peritoneal cavity of mice were distributed immediately to all organs examined and maintained a high titer for at least 24 h. They were stable in the urine of both mice and humans for 24 h at 37°C. Administration of these phages into the peritoneal cavity caused a marked decrease in the mortality of mice inoculated transurethrally with a UPEC strain, whereas most of the control mice died within a few days of bacterial infection. Inoculation with phage alone produced no adverse effects attributable to the phage per se. The present study experimentally demonstrated the therapeutic potential of phage for E. coli-induced UTIs, and T-even-related phages may be suitable candidates with which to treat them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ackermann HW (2007) 5500 bacteriophages examined in the electron microscope. Arch Virol 152:227–243

    Article  PubMed  CAS  Google Scholar 

  2. Alisky J, Iczkowski K, Rapoport A, Troitsky N (1998) Bacteriophages show promise as antimicrobial agents. J Infect 36:5–15

    Article  PubMed  CAS  Google Scholar 

  3. Barrow P, Lovell M, Berchieri A Jr (1998) Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol 5:294–298

    PubMed  CAS  Google Scholar 

  4. Carlton RM (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp 47:267–274

    CAS  Google Scholar 

  5. Chibani-Chennoufi S, Sidoti J, Bruttin A, Dillmann M-L, Kutter E, Qadri F, Sarker SA, Brüssow H (2004) Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh. J Bacteriol 186:8287–8294

    Article  PubMed  CAS  Google Scholar 

  6. Filée J, Tétart F, Suttle CA, Krisch HM (2005) Marine T4-type bacteriophages, a ubiquitous component of the dark matter of the biosphere. Proc Natl Acad Sci 102:12471–12476

    Article  PubMed  Google Scholar 

  7. Geier MR, Trigg ME, Merril CR (1973) Fate of bacteriophage lambda in non-immune germ-free mice. Nature 246:221–223

    Article  PubMed  CAS  Google Scholar 

  8. Glantz SA (2002) Primer of biostatistics, 5th edn. McGrau Hill Medical Publishing Division. New York

    Google Scholar 

  9. Ho K (2001) Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med 44:1–16

    Article  PubMed  CAS  Google Scholar 

  10. Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM (2003) Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. Poult Sci 82:1108–1112

    PubMed  CAS  Google Scholar 

  11. Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM (2003) Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis 47:1399–1405

    Article  PubMed  CAS  Google Scholar 

  12. Huff WE, Huff GR, Rath NC, Donoghue AM (2006) Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens. Poult Sci 85:1373–1377

    PubMed  CAS  Google Scholar 

  13. Matsuzaki S, Inoue T, Tanaka S (1998) A vibriophage, KVP40, with major capsid protein homologous to gp23* of coliphage T4. Virology 242:314–318

    Article  PubMed  CAS  Google Scholar 

  14. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage ϕMR11. J Infect Dis 187:613–624

    Article  PubMed  CAS  Google Scholar 

  15. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 93:3188–3192

    Article  PubMed  CAS  Google Scholar 

  16. Merril CR, Scholl D, Adhya L (2003) The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2:489–497

    Article  PubMed  CAS  Google Scholar 

  17. Muratani T, Matsumoto T (2004) Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents 24S:S28–S31

    Article  Google Scholar 

  18. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F (2006) Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 12:279–284

    Article  PubMed  CAS  Google Scholar 

  19. Sahm DF, Thornsberry C, Mayfield DC, Jones ME (2001) Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45:1402–1406

    Article  PubMed  CAS  Google Scholar 

  20. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

    Google Scholar 

  21. Smith HW, Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128:307–318

    PubMed  CAS  Google Scholar 

  22. Smith HW, Huggins MB (1983) Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets, and lambs. J Gen Microbiol 129:2659–2675

    PubMed  CAS  Google Scholar 

  23. Smith HW, Huggins MB, Shaw KM (1987) The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133:1111–1126

    PubMed  CAS  Google Scholar 

  24. Smith HW, Huggins MB, Shaw KM (1987) Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133:1127–1135

    PubMed  CAS  Google Scholar 

  25. Sulakvelidze A, Alavidze Z, Morris JG Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649–659

    Article  PubMed  CAS  Google Scholar 

  26. Summers WC (1999) Félix d’Herelle and the origins of molecular biology. Yale University Press, New Haven

    Google Scholar 

  27. Tétart F, Desplats C, Krisch HM (1998) Genome plasticity in the distal tail fiber locus of the T-even bacteriophage: recombination between conserved motifs swaps adhesin specificity. J Mol Biol 282:543–556

    Article  PubMed  Google Scholar 

  28. Tétart F, Desplats C, Kutateladze M, Monod C, Ackermann HW, Krisch M (2001) Phylogeny of the major head and tail genes of the wide-ranging T4-type bacteriophages. J Bacteriol 183:358–366

    Article  PubMed  Google Scholar 

  29. Thacker PD (2003) Set a microbe to kill a microbe: drug resistance renews interest in phage therapy. JAMA 290:3183–3185

    Article  PubMed  CAS  Google Scholar 

  30. Watanabe R, Matsumoto T, Sano G, Ishii Y, Tateda K, Sumiyama Y, Uchiyama J, Sakurai S, Matsuzaki S, Imai S, Yamaguchi K (2007) Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 51:446–452

    Article  PubMed  CAS  Google Scholar 

  31. Weber-Dabrowska B, Mulczyk M, Górski A (2000) Bacteriophage therapy of bacterial infections: an update of our institute’s experience. Arch Immunol Ther Exp 48:547–551

    CAS  Google Scholar 

  32. Zuber S, Ngom-Bru C, Barretto C, Bruttin A, Brüssow H, Denou H (2007) Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli. J Bacteriol 189:8206–8214

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was partly supported by grants from the Ministry of Education, Science, Sports, and Culture, Japan [16659265].

Author information

Authors and Affiliations

  1. Department of Urology, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan

    H. Nishikawa, M. Yasuda & T. Shuin

  2. Department of Pediatrics, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan

    J. Uchiyama & Y. Maeda

  3. Department of Microbiology and Infection, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan

    J. Uchiyama, M. Rashel, Y. Maeda, I. Takemura, Y. Shimizu & S. Matsuzaki

  4. Department of Biochemistry, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan

    I. Takemura

  5. Clinical Laboratory Center of Kochi Medical School Hospital, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan

    S. Sugihara

  6. Section of Life Science and Biofunctional Materials, Science Research Center of Kochi University, Nankoku, Kochi, 783-8505, Japan

    T. Ujihara

Authors
  1. H. Nishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Rashel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Takemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Sugihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Ujihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y. Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. T. Shuin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. Matsuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Matsuzaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishikawa, H., Yasuda, M., Uchiyama, J. et al. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections. Arch Virol 153, 507–515 (2008). https://doi.org/10.1007/s00705-007-0031-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-007-0031-4

Keywords

Search

Navigation